SAMRAT PHARMACHEM LTD.-$

Company Profile

SAMRAT PHARMACHEM LTD.-$ had its IPO on under the ticker symbol SAMRATPH.

The company operates in the sector and industry. SAMRAT PHARMACHEM LTD.-$ has a staff strength of 0 employees.

Stock update

Shares of SAMRAT PHARMACHEM LTD.-$ opened at ₹409.7 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹388.1 - ₹409.7, and closed at ₹397.2.

This is a -1.74% slip from the previous day's closing price.

A total volume of 11,461 shares were traded at the close of the day’s session.

In the last one week, shares of SAMRAT PHARMACHEM LTD.-$ have slipped by -1.51%.

SAMRAT PHARMACHEM LTD.-$'s Key Ratios

SAMRAT PHARMACHEM LTD.-$ has a market cap of ₹1.66 billion, indicating a price to book ratio of 3.8648 and a price to sales ratio of 0.8791.

In the last 12-months SAMRAT PHARMACHEM LTD.-$’s revenue was ₹0 with a gross profit of ₹101.71 million and an EBITDA of ₹0. The EBITDA ratio measures SAMRAT PHARMACHEM LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SAMRAT PHARMACHEM LTD.-$’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, SAMRAT PHARMACHEM LTD.-$’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

SAMRAT PHARMACHEM LTD.-$’s PE and PEG Ratio

Forward PE

0

Trailing PE

52.5442

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SAMRAT PHARMACHEM LTD.-$’s profitability.

SAMRAT PHARMACHEM LTD.-$ stock is trading at a EV to sales ratio of 0.944 and a EV to EBITDA ratio of 6.4306. Its price to sales ratio in the trailing 12-months stood at 0.8791.

SAMRAT PHARMACHEM LTD.-$ stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 1.78%.

Balance sheet and cash flow metrics

Total Assets

₹1.11 billion

Total Liabilities

₹416.79 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

1.78%

SAMRAT PHARMACHEM LTD.-$ ended 2025 with ₹1.11 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.11 billion while shareholder equity stood at ₹621.01 million.

SAMRAT PHARMACHEM LTD.-$ ended 2025 with ₹0 in deferred long-term liabilities, ₹416.79 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹89.81 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹68.36 million.

SAMRAT PHARMACHEM LTD.-$’s total current assets stands at ₹991.17 million while long-term investments were ₹0 and short-term investments were ₹18.92 million. Its net receivables were ₹537.00 million compared to accounts payable of ₹144.58 million and inventory worth ₹338.19 million.

In 2025, SAMRAT PHARMACHEM LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SAMRAT PHARMACHEM LTD.-$ paid ₹0.02 in dividends in 2025.

Other key metrics

Current Trading Price

₹397.2

52-Week High

₹1248.9183

52-Week Low

₹332

Analyst Target Price

₹

SAMRAT PHARMACHEM LTD.-$ stock is currently trading at ₹397.2 per share. It touched a 52-week high of ₹1248.9183 and a 52-week low of ₹1248.9183. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹421.55 and 200-day moving average was ₹531.22 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.